Current Report Filing (8-k)
October 12 2022 - 04:04PM
Edgar (US Regulatory)
0001630176 false 0001630176 2022-10-07
2022-10-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of Report (Date of earliest event reported):
|
|
October 7, 2022
|
HEALTHY EXTRACTS INC.
(Exact name of registrant as specified in its charter)
Nevada
|
|
333-202542
|
|
47-2594704
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
|
|
|
|
|
7375 Commercial Way, Suite 125
Henderson, NV 89011
(Address of principal executive offices) (zip code)
|
|
|
|
|
|
|
|
|
|
|
(702) 463-1004
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
|
|
|
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If
an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Section 1 – Registrant’s Business and Operations
Item 1.01 Entry into a Material Definitive Agreement.
On
October 7, 2022, our wholly-owned subsidiary, BergaMet NA, LLC
entered into a Loan Agreement with Amazon Capital Services, Inc. to
borrow $200,000. The loan bear interest at an annual rate of 12.99%
and is secured by our inventory and account at Amazon, as well as
our other assets. For the first 3 months, payments are interest
only at $2,165.00 per month, and for months 4 through 12, payments
are principal and interest at $23,442.27 per month. The proceeds
from the loan will support our selling efforts on Amazon’s website.
Section 9 – Financial Statements and Exhibits.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
Healthy Extracts Inc.
|
|
|
|
|
Dated: October 11, 2022
|
/s/
Kevin Pitts
|
|
By:Kevin
“Duke” Pitts
|
|
Its:President
|
Healthy Extracts (QB) (USOTC:HYEX)
Historical Stock Chart
From May 2023 to Jun 2023
Healthy Extracts (QB) (USOTC:HYEX)
Historical Stock Chart
From Jun 2022 to Jun 2023